Trademarkia Logo

Canada

C$
SUNPHARMA
ADVERTISED

on 5 Feb 2025

Last Applicant/ Owned by

SUN PHARMACEUTICAL INDUSTRIES LIMITED

Sun House, Plot No. 201 B/1Western Express Highway, Goregaon (E)Mumbai, Maharashtra, 400063

IN

Serial Number

1972425 filed on 24th Jun 2019

Correspondent Address

MICHELLE L. WASSENAAR

(METHOD LAW PROFESSIONAL CORPORATION)4211 Yonge StreetSuite 310Toronto

ONTARIO

CA

M2P2A9

SUNPHARMA

Trademark usage description

pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, a Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of psychiatric diseases, degenerative nerve diseases and brain disorders, namely, mood, anxiety, schizophrenia and cognitive disorders, Alzheimer's disease, cerebral palsy, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the prevention and treatment of cranial and facial nerve disorders, connective tissue injuries, diseases and disorders, bone and cartilage injuries, diseases and disorders; pharmaceutical preparations for the prevention and treatment of neuromuscular and neurological diseases and disorders, namely, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, muscle diseases and disorders, namely inflammatory muscle diseases and disorders, and muscular dystrophy, ocular motility and spinal cord infections, injuries and diseases, and seizure disorders; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, inflammatory pelvic diseases, urological and reproductive system diseases, disorders and infections, namely, sexually transmitted diseases, erectile and sexual dysfunction, infertility and incontinence; pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; pharmaceutical preparations for the prevention and treatment of auto-immune, cardiovascular, gastrointestinal, hematologic, oncological, ophthalmological and respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of allergies, hypertension, menopause, diabetic neuropathy, arthritis, and pain; antibiotics, anti-infectives, anti-inflammatories, anti-fungals, anti-virals, oral and injectable pharmaceutical contraceptives, human vaccines; pharmaceutical preparations for the prevention and treatment of smoking habits and addictions; pharmaceutical preparations for the prevention and treatment of renal disease and disorders; pharmaceutical preparations for the prevention and treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the prevention and treatment of muscular atrophy; pharmaceutical preparations for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, muscular dystrophy, sickle cell disease, and anemia; pharmaceutical preparations for the prevention and treatment of cerebrovascular diseases and digital ulcers; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, psoriasis; dietary and nutritional supplements for general health and well-being; nutritional supplements for promoting weight loss; anti-aging nutritional supplements; dietary and nutritional supplements for treatment of bloating and constipation; dietary and nutritional supplements for supporting and providing energy during exercise; dietary and nutritional supplements for promoting muscle recovery after exercise; dietary and nutritional supplements for appetite suppression; nutritional supplements to aid digestion; dietary and nutritional supplements to aid sleeping and treat insomnia; dietary and nutritional supplements for relieving and reducing stress and promoting relaxation; dietary and nutritional supplements to boost the immune system; dietary and nutritional supplements to promote healthy aging; dietary and nutritional supplements for relieving bone and joint pain management; dietary and nutritional supplements for the treatment of digestive complaints, namely, IBS, Crohn's, colitis, diarrhea, hormonal imbalance, namely, menopause, polycystic ovaries, infertility, endometriosis, kidney disease, heart disease, atherosclerosis, high blood pressure, high cholesterol, liver disease, lung disease, eye diseases, namely, cataracts, macular degeneration, glaucoma, cold and flu, sore throat, stress, fatigue, headaches, migraines, muscular tension, muscle pain and memory


Classification kind code

11

Mark Details


Serial Number

1972425

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 27
on 13th Jan 2025
Approval Notice Sent
Submitted for opposition 48
on 6th Dec 2024
Agent Changed
Submitted for opposition 14
on 8th Oct 2024
Default Notice Sent
Submitted for opposition 135
on 3rd Oct 2024
Amendment to Application
Submitted for opposition 22
on 18th Mar 2024
Search Recorded
Submitted for opposition 20
on 18th Mar 2024
Examiner's First Report
Submitted for opposition 287
on 1st Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 3rd Jul 2019
Formalized
Submitted for opposition 1
on 25th Jun 2019
Created
Submitted for opposition 30
on 24th Jun 2019
Filed